Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2195042 | 1.00 | SLC6A5 (0.47) | SLC6A5FAAHDNM1HDAC3HDAC1 | |
| SCHEMBL5892041 | 0.93 | TSHR (0.45) | SLC6A5FAAHHDAC3HDAC1HDAC2 | |
| SCHEMBL20710352 | 0.93 | SLC6A5 (0.51) | SLC6A5FAAHDNM1HDAC3HDAC1 | |
| SCHEMBL10057792 | 0.93 | SLC6A5 (0.51) | SLC6A5FAAHDNM1HDAC3HDAC1 | |
| SCHEMBL14198853 | 0.91 | SLC6A5 (0.49) | SLC6A5FAAHDNM1HDAC3HDAC1 | |
| SCHEMBL16421586 | 0.89 | SLC6A5 (0.57) | SLC6A5FAAHDNM1 | |
| SCHEMBL22289072 | 0.89 | SLC6A5 (0.57) | SLC6A5FAAHDNM1 | |
| SCHEMBL28352481 | 0.89 | FAAH (0.50) | SLC6A5FAAHDNM1HDAC3HDAC1 | |
| SCHEMBL2217380 | 0.89 | FAAH (0.50) | SLC6A5FAAHDNM1HDAC3HDAC1 | |
| SCHEMBL19382820 | 0.88 | SLC6A5 (0.61) | SLC6A5FAAHDNM1CASP2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9493583-B2 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ADOCIA (FR) | 2016-11-15 | — | — | US | disclosed |
| US-20110172166-A1 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ADOCIA (FR) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172166-A1 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ALG1, CD44, FUT6 | SLC6A5 1565/4885FAAH 3193/4885DNM1 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.